Hortensia Zelaya Selected Research

Fibrin

12/2020	Lactobacillus casei CRL431 modulates hemostatic activation induced by protein malnourishment and pneumococcal respiratory infection.
1/2011	Coagulation activation in an experimental pneumonia model in malnourished mice.
10/2009	Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hortensia Zelaya Research Topics

Disease

7	Infections 12/2020 - 10/2009
4	Pneumococcal Infections 12/2020 - 10/2013
2	Respiratory Syncytial Virus Infections 01/2017 - 08/2013
2	Pneumococcal Pneumonia 01/2017 - 07/2014
2	Inflammation (Inflammations) 01/2016 - 07/2014
1	Malnutrition (Nutritional Deficiencies) 12/2020
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Superinfection 01/2017
1	Bacteremia 01/2017
1	Lung Injury 08/2015
1	Acute Lung Injury 01/2014
1	Body Weight (Weight, Body) 11/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2013
3	FibrinIBA 12/2020 - 10/2009
3	Antiviral Agents (Antivirals)IBA 01/2017 - 08/2013
2	Hemostatics (Antihemorrhagics)IBA 12/2020 - 07/2014
2	CytokinesIBA 01/2017 - 08/2015
1	Proteinase-Activated ReceptorsIBA 12/2020
1	CoagulantsIBA 12/2020
1	Thromboplastin (Tissue Factor)IBA 12/2020
1	Toll-Like Receptor 3IBA 01/2017
1	Peptidoglycan (Murein)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 08/2015
1	Toll-Like Receptor 2IBA 07/2014
1	LipopolysaccharidesIBA 01/2014
1	Transferrin (beta 2 Transferrin)IBA 11/2013
1	AlbuminsIBA 01/2013
1	Peroxidase (Myeloperoxidase)IBA 01/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2013
1	estropipate (Ogen)FDA LinkGeneric 01/2011
1	Fibrinogen (Factor I)FDA Link 01/2011

Therapy/Procedure

2	Intranasal Administration 08/2015 - 01/2013
1	Oral Administration 07/2012